Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the src SH2 domain binding

被引:55
作者
Nam, NH
Ye, GF
Sun, GQ
Parang, K [1 ]
机构
[1] Univ Rhode Isl, Dept Biomed Sci, Kingston, RI 02881 USA
[2] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA
关键词
D O I
10.1021/jm040008+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of conformationally constrained peptides were designed and synthesized as the Src SH2 domain ligands based on a tetrapeptide sequence pTyr-Glu-Glu-Ile (pYEEI). In general, the constrained peptides such as compounds 6, 7, and 11 (IC50 = 1.1-1.5 muM) showed higher binding affinities to the Src SH2 domain relative to the corresponding linear peptides 8a, 9a, and 13a, respectively (IC50 > 100 muM), and pYEEI (IC50 = 6.5 muM), as evaluated by a fluorescence polarization assay. Molecular modeling studies revealed that in constrained peptides, the isoleucine side chain penetrates very deeply into the hydrophobic binding pocket (P + 3 site) of the Src SH2 domain. These constrained peptides can serve as novel templates for the design of small and nonpeptidic inhibitors of the Src SH2 domain.
引用
收藏
页码:3131 / 3141
页数:11
相关论文
共 50 条
  • [11] Inhibitors of the Src SH2 domain and Src tyrosine kinase as potential anticancer drugs
    Tranter, D
    DRUG DISCOVERY TODAY, 2001, 6 (04) : 215 - 216
  • [12] Development of peptoid-peptide hybrids as She SH2 domain - binding inhibitors
    Kim, Sung-Eun
    Choi, Won Jun
    Stephen, Andrew G.
    Weidlich, Iwona E.
    Giubellino, Alessio
    Liu, Fa
    Worthy, Karen M.
    Bindu, Lakshman
    Fivash, Matthew J.
    Nicklaus, Marc C.
    Bottaro, Donald
    Fisher, Robert J.
    Burke, Terrence R., Jr.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [13] Role of electrostatic interactions in SH2 domain recognition: Salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase
    Grucza, RA
    Bradshaw, JM
    Mitaxov, V
    Waksman, G
    BIOCHEMISTRY, 2000, 39 (33) : 10072 - 10081
  • [14] Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain
    Ye, GF
    Ayrapetov, M
    Nam, NH
    Sun, GQ
    Parang, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (22) : 4994 - 4997
  • [15] Synthesis of GRB2 SH2 domain inhibitors: Analogues of sclerotiorin
    Gladfelder, Joshua
    Arpin, Carolynn
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [16] Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain
    Stover, DR
    Furet, P
    Lydon, NB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12481 - 12487
  • [17] USE OF PEPTOID-PEPTIDE HYBRIDS IN THE DEVELOPMENT OF She SH2 DOMAIN -BINDING INHIBITORS
    Kim, S.
    Choi, W.
    Stephen, A.
    Weidlich, I.
    Giubellino, A.
    Liu, F.
    Worthy, K.
    Bindu, L.
    Fivash, M.
    Nicklaus, M.
    Bottaro, D.
    Fisher, R.
    Burke, T., Jr.
    BIOPOLYMERS, 2009, 92 (04) : 352 - 352
  • [18] Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing α-methylphenylalanyl based phosphotyrosyl mimetics
    Oishi, S
    Karki, RG
    Kang, SU
    Wang, XZ
    Worthy, KM
    Bindu, LK
    Nicklaus, MC
    Fisher, RJ
    Burke, TR
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) : 764 - 772
  • [19] Diversity in the SH2 domain family phosphotyrosyl peptide binding site
    Campbell, SJ
    Jackson, RM
    PROTEIN ENGINEERING, 2003, 16 (03): : 217 - 227
  • [20] Potent dipeptide inhibitors of the pp60c-src SH2 domain
    Pacofsky, GJ
    Lackey, K
    Alligood, KJ
    Berman, J
    Charifson, PS
    Crosby, RM
    Dorsey, GF
    Feldman, PL
    Gilmer, TM
    Hummel, CW
    Jordan, SR
    Mohr, C
    Shewchuk, LM
    Sternbach, DD
    Rodriguez, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) : 1894 - 1908